Prof. David Meiri’s Groundbreaking Work
Exciting news is coming from Israel's Technion Institute, where Prof. David (Dedi) Meiri, a leading scientist in cancer and cannabis research, is making groundbreaking strides. Prof. Meiri believes that the endocannabinoid system in our bodies could revolutionize cancer treatment. His team has developed cannabis-based medicines that target immunosuppressive cancers like melanoma and lung cancer, as well as estrogen receptor-positive breast cancer.
These innovative treatments will soon be available in Israel, marking a significant advancement in the fight against cancer.
Understanding the Endocannabinoid System
Prof. Meiri's research is centered on the endocannabinoid system, a complex network that helps maintain balance in our bodies. This system includes over 100 naturally occurring endocannabinoids and a vast array of receptors found in every cell and system. Each of the body’s 200+ cell types, from red blood cells to neurons, has a unique combination of cannabinoid receptors that respond to specific endocannabinoid combinations.
Phytocannabinoids: Nature’s Cancer Fighters
What's fascinating is that phytocannabinoids, the compounds found in the cannabis plant, can mimic the body's endocannabinoids. These phytocannabinoids can activate specific receptors to promote healing and combat diseases, including cancer. Prof. Meiri's team is dedicated to identifying which combinations of cannabinoids are most effective in targeting cancer cells.
The Entourage Effect: A Synergistic Approach
One key concept in their research is the "entourage effect," popularized by Prof. Raphael Mechoulam. This effect suggests that using the whole cannabis plant provides more beneficial outcomes than isolated compounds due to their synergistic interactions. Prof. Meiri takes this idea further by exploring how the body's different systems—immune, digestive, nervous, muscular, and reproductive—can work together to combat diseases. For instance, cannabinoids might target both the immune and colon systems simultaneously for better treatment outcomes in conditions like inflammatory bowel disease (IBD).
Beyond Symptom Management: Inducing Cancer Cell Death
Cannabis also holds promise in managing the debilitating side effects of cancer treatment, such as pain, anxiety, nausea, and insomnia. Moreover, cannabinoids have shown potential in inducing cancer cell death, which could significantly improve the quality of life and treatment outcomes for cancer patients.
Precision Medicine: Tailoring Treatment to Patients
Prof. Meiri's team uses data from Israel's medical cannabis program to analyze how patients respond to specific cannabis strains for various health conditions. By dissecting these strains, they identify the active compounds and understand their effects on different cell receptors. This approach is the first step toward developing precision cannabis medicine tailored to individual patient needs.
Cancer’s Hidden Threat and a Ray of Hope
Cancer cells are notorious for hiding from the immune system, allowing them to form deadly tumors undetected. Current treatments like chemotherapy, immunotherapy, radiation, and surgery are all used to fight cancer, but a definitive cure remains elusive. Prof. Meiri’s research offers hope, particularly with their discovery of a specific cannabinoid that blocks estrogen receptors, potentially inhibiting the growth of certain breast cancers.
Cannabis and Immunotherapy: A Promising Combination
Immunotherapy, which boosts the immune system to attack cancer cells, is another area where Prof. Meiri's team has made significant strides. Their clinical trials have shown that while some cannabis strains had no impact on immunotherapy, others worked synergistically. It took five years of research to identify and test the strains that enhance immunotherapy treatment.
A Bright Future for Cannabis-Based Medicine
Looking ahead, Prof. Meiri is optimistic about the future of cannabis-based medicine. He receives countless calls from cancer patients' friends and family seeking alternative treatments. Soon, his team's formulation for treating immunosuppressive cancers like melanoma and lung cancer will be available in Israel, with hopes for future FDA approval in the United States. The team continues to work on finding cures for other cancers, including breast cancer and leukemia, with predictions that other strain-specific formulations will be available within a few years.
Prof. Meiri’s Dedication and Vision
Prof. Meiri's groundbreaking research on the endocannabinoid system offers immense hope in the fight against cancer. By leveraging the entourage effect and strain-specific cannabinoid combinations, cannabis-based medicine holds the potential to treat various cancers and manage debilitating side effects. While challenges remain, the dedication of Prof. Meiri and his team, along with the growing body of research, suggests that cannabis medicine may soon become a powerful weapon in our fight against this devastating disease.
For more information about GrowthStalk and our initiatives, follow us on social media:
Instagram: @buygstk
Facebook: @growthstalk
Twitter: @growthstalk
YouTube: @growthstalk
Comments